PONIARD PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 USD | -0.99% |
|
-.--% | -.--% |
Financials (USD)
| Sales 2009 | - | Sales 2010 | - | Capitalization | 25.13M |
|---|---|---|---|---|---|
| Net income 2009 | -45M | Net income 2010 | -30M | EV / Sales 2009 | - |
| Net cash position 2009 | 23.12M | Net cash position 2010 | 2.76M | EV / Sales 2010 | - |
| P/E ratio 2009 |
-1.4
x | P/E ratio 2010 |
-0.79
x | Employees | 8 |
| Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 2.5% |
More Fundamentals
* Assessed data
| 1 day | -0.99% |
Current year
0.00
0.00
1 year
0.000.00
3 years
0.000.10
5 years
0.000.12
10 years
0.000.45
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of oncology products to impact the lives of people with cancer. It develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The Company has offices in San Francisco, California; and Seattle, Washington in United States.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 149 | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| -9.14% | 11.95B | |
| +5.24% | 8.71B | |
| -8.42% | 8.12B |
- Stock Market
- Equities
- PARD Stock
